WHO ICTRP trial
Observational study of the benefits of rectal ozonotherapy and BIOPLA as…
RPCEC00000342 · Registro Público Cubano de Ensayos Clínicos (RPCEC) · Not Recruiting
Key facts
| Trial ID | RPCEC00000342 |
|---|---|
| Public title | Observational study of the benefits of rectal ozonotherapy and BIOPLA as complemetary theraphy in convalescent patients with SARS-COV 2 |
| Scientific title | Observational study of the benefits of rectal ozonotherapy and BIOPLA as complementary therapy in convalescent patients with SARS-COV 2 (COVID-19) - EST-OBS-OZO-BIOPLA-SARS-COV 2 |
| Primary sponsor | National Center for Scientific Research |
| Secondary sponsors | Placentary Histotherapy Center |
| Registry | Registro Público Cubano de Ensayos Clínicos (RPCEC) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Countries | Cuba |
| Conditions | COVID-19 COVID-19 SARS-CoV2;Coronavirus Infections;SARS Virus;Coronaviridae Infections;Nidovirales Infections;Betacoronavirus;COVID-19 ;SARS-CoV2 |
| Interventions | Group 1: Rectal ozonotherapy in combination with BIOPLA. Rectal ozonotherapy aplication (200 mL gas with 30 µg/mL ozono concentration), 5 days/week during 4 weeks plus BIOPLA (1 capsule-500mg)/dayafter lunch, during 4 weeks. Group 2: BIOPLA… |
| Registration date | Jun 11, 2020 |
| Target size | 40 |
| Secondary IDs | Conv/COVID19/2020 |
| Registry page | rpcec.sld.cu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: